Yannoutsos N - Search Results

1

Expression of human decay accelerating factor in transgenic pigs.

Cozzi E, Langford GA, Richards A, Elsome K, Lancaster R, Chen P, Yannoutsos N, White DJ. Cozzi E, et al. Among authors: yannoutsos n. Transplant Proc. 1994 Jun;26(3):1402-3. Transplant Proc. 1994. PMID: 7518135 No abstract available.

2

Production of pigs transgenic for human decay accelerating factor.

Langford GA, Yannoutsos N, Cozzi E, Lancaster R, Elsome K, Chen P, Richards A, White DJ. Langford GA, et al. Among authors: yannoutsos n. Transplant Proc. 1994 Jun;26(3):1400-1. Transplant Proc. 1994. PMID: 7518134 No abstract available.

3

Comparative analysis of human DAF expression in the tissues of transgenic pigs and man.

Cozzi E, Langford GA, Wright L, Tucker A, Yannoutsos N, Richards A, Rosengard A, Elsome K, Lancaster R, White DJ. Cozzi E, et al. Among authors: yannoutsos n. Transplant Proc. 1995 Feb;27(1):319-20. Transplant Proc. 1995. PMID: 7533397 No abstract available.

4

Expression of human DAF and MCP on pig endothelial cells protects from human complement.

Carrington CA, Richards AC, Cozzi E, Langford G, Yannoutsos N, White DJ. Carrington CA, et al. Among authors: yannoutsos n. Transplant Proc. 1995 Feb;27(1):321-3. Transplant Proc. 1995. PMID: 7533398 No abstract available.

5

Production of pigs transgenic for human regulators of complement activation.

Yannoutsos N, Langford GA, Cozzi E, Lancaster R, Elsome K, Chen P, White DJ. Yannoutsos N, et al. Transplant Proc. 1995 Feb;27(1):324-5. Transplant Proc. 1995. PMID: 7533399 No abstract available.

6

Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection.

Cary N, Moody J, Yannoutsos N, Wallwork J, White D. Cary N, et al. Among authors: yannoutsos n. Transplant Proc. 1993 Feb;25(1 Pt 1):400-1. Transplant Proc. 1993. PMID: 7679815 No abstract available.

7

Longitudinal analysis of the expression of human decay accelerating factor on peripheral blood mononuclear cells and in the plasma of transgenic pigs.

Cozzi E, Langford GA, Wright L, Pino-Chávez G, Levy A, Chatterjee M, Yannoutsos N, Miller N, Lancaster R, White DJ. Cozzi E, et al. Among authors: yannoutsos n. Transplant Proc. 1996 Apr;28(2):860-1. Transplant Proc. 1996. PMID: 8623437 No abstract available.

8

Production of pigs transgenic for human regulators of complement activation using YAC technology.

Langford GA, Cozzi E, Yannoutsos N, Lancaster R, Elsome K, Chen P, White DJ. Langford GA, et al. Among authors: yannoutsos n. Transplant Proc. 1996 Apr;28(2):862-3. Transplant Proc. 1996. PMID: 8623438 No abstract available.

9

Production of pigs transgenic for human DAF to overcome complement-mediated hyperacute xenograft rejection in man.

White DJ, Yannoutsos N. White DJ, et al. Among authors: yannoutsos n. Res Immunol. 1996 Feb;147(2):88-94. doi: 10.1016/0923-2494(96)87179-3. Res Immunol. 1996. PMID: 8792466 Review. No abstract available.

10

Human CD46 but not CD59 in transgenic mice protects against hyperacute rejection evoked by ex vivo perfusion with human serum.

Marquet RL, van Stijn I, van den Tol PM, Bonthuis F, Yannoutsos N, IJzermans JN. Marquet RL, et al. Among authors: yannoutsos n. Transplant Proc. 1997 Feb-Mar;29(1-2):931-2. doi: 10.1016/s0041-1345(96)00250-3. Transplant Proc. 1997. PMID: 9123592 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters